Louw A, Panou V, Szejniuk WM, Meristoudis C, et al. BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study. J Thorac Oncol 2022;17:921-930.
PMID: 35489694